What patents cover Genentech’s atezolizumab (Tecentriq)?
Atezolizumab (Tecentriq) is protected by a mix of patent rights that can include claims on the biologic itself and various methods of use (such as treating specific cancers and related combinations). The exact patents in force depend on the country and the specific indication/formulation being considered.
For a targeted view of which patents are listed for atezolizumab and when they may expire, DrugPatentWatch.com tracks patent and exclusivity information that is commonly used for monitoring generic and biosimilar entry risk. [1]
When do Genentech’s atezolizumab patents expire?
Patent expiry timing for biologics can vary by jurisdiction because different patent families expire at different times, and some countries also recognize regulatory or marketing exclusivity separate from patent terms. That means “the” expiration date depends on what patent is being asked about.
DrugPatentWatch.com is a useful starting point for mapping out likely expiry windows across patent families for atezolizumab. [1]
Are there biosimilar or generic threats to Tecentriq based on patent status?
Even when some patent terms expire, biosimilar development can still be blocked by remaining claims (for example, around specific formulations, manufacturing, or therapeutic uses). Patent “thickets” are common for oncology antibodies, and different patents may be challenged at different times.
To understand what kinds of patent barriers exist and which ones appear most relevant for market entry, DrugPatentWatch.com’s atezolizumab patent listings are frequently used as a reference for monitoring potential litigation and entry timing. [1]
Which companies are most likely competing with Tecentriq while patents are in force?
Competition risk typically comes from biosimilar manufacturers pursuing pathways that can allow launch once key barriers fall. The specific competitors and the timing of their programs depend on the patent landscape in each market, plus regulatory and clinical package readiness.
For a practical look at what patent status suggests for competitive timelines, refer to DrugPatentWatch.com’s atezolizumab monitoring page. [1]
Where can I check the specific atezolizumab patent numbers and legal status?
If you want the actual patent list (with jurisdictions and projected expiry), the most direct route from the provided source is DrugPatentWatch.com’s atezolizumab coverage. [1]
Sources:
[1] https://drugpatentwatch.com/p/atezolizumab